• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺奴卡菌病:高负担中心的危险因素和菌种分布。

Pulmonary nocardiosis: Risk factors and species distribution from a high burden centre.

机构信息

Department of Clinical Microbiology, CMC Vellore, Tamil Nadu, India.

Department of Clinical Microbiology, CMC Vellore, Tamil Nadu, India.

出版信息

Indian J Med Microbiol. 2022 Oct-Dec;40(4):582-584. doi: 10.1016/j.ijmmb.2022.08.010. Epub 2022 Sep 8.

DOI:10.1016/j.ijmmb.2022.08.010
PMID:36088197
Abstract

Nocardiosis is a clinical and diagnostic challenge. This was a retrospective study carried out on cases of pulmonary nocardiosis presenting over 15 years. Clinical data was retrieved using the electronic patient records. Vitek MS 3.2 (MALDI TOF MS) was carried out on 22 isolates and sequencing on another 9 isolates. Of 71 patients presenting with pulmonary nocardiosis, 58 (81.6%) were on immunosuppressant therapy, 26 (46%) had a previous lung pathology, 11 (8%) were HIV associated. Disseminated disease was seen in 6 (8.4%). There were 8 (11.26%) deaths in this cohort of patients. Of 31/71 identified to species, the most common were Nocardia cyriacigeorgica (n ​= ​11) followed by Nocardia farcinica (n ​= ​9).

摘要

奴卡菌病是一种临床和诊断上的挑战。这是一项对超过 15 年期间出现的肺部奴卡菌病病例进行的回顾性研究。使用电子病历检索临床数据。对 22 株分离株进行了 Vitek MS 3.2(MALDI-TOF MS)检测,对另外 9 株分离株进行了测序。在 71 例患有肺部奴卡菌病的患者中,58 例(81.6%)正在接受免疫抑制剂治疗,26 例(46%)有既往肺部病理学,11 例(8%)与 HIV 相关。6 例(8.4%)患者出现播散性疾病。该患者队列中有 8 例(11.26%)死亡。在 71 例鉴定到种的患者中,最常见的是触须奴卡菌(n=11),其次是星形奴卡菌(n=9)。

相似文献

1
Pulmonary nocardiosis: Risk factors and species distribution from a high burden centre.肺奴卡菌病:高负担中心的危险因素和菌种分布。
Indian J Med Microbiol. 2022 Oct-Dec;40(4):582-584. doi: 10.1016/j.ijmmb.2022.08.010. Epub 2022 Sep 8.
2
Nocardiosis at the turn of the century.世纪之交的诺卡菌病。
Medicine (Baltimore). 2009 Jul;88(4):250-261. doi: 10.1097/MD.0b013e3181afa1c8.
3
Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece.诺卡氏菌病的临床和微生物学特征:希腊克里特岛 5 年单中心研究。
Acta Microbiol Immunol Hung. 2023 Jul 17;70(3):239-245. doi: 10.1556/030.2023.02071. Print 2023 Sep 21.
4
Rare case of osteomyelitis of tibial shaft caused by Nocardia cyriacigeorgica.由乔治西诺卡菌引起的胫骨干骨髓炎罕见病例。
Folia Microbiol (Praha). 2018 Jul;63(4):525-532. doi: 10.1007/s12223-018-0589-0. Epub 2018 Mar 5.
5
Revisiting nocardiosis at a tertiary care institution: Any change in recent years?再次探讨三级医疗机构的奴卡菌病:近年来有任何变化吗?
Int J Infect Dis. 2021 Jan;102:446-454. doi: 10.1016/j.ijid.2020.10.087. Epub 2020 Nov 3.
6
Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020.2011-2020 年台湾一家三甲医院诺卡菌属的临床表现和抗菌药物敏感性。
J Formos Med Assoc. 2022 Oct;121(10):2109-2122. doi: 10.1016/j.jfma.2022.06.011. Epub 2022 Jul 8.
7
Isolation and Characterization of Nocardia Species from Pulmonary Nocardiosis in a Tertiary Hospital in China.从中国一家三级医院的肺部诺卡氏菌病中分离和鉴定诺卡氏菌种。
Jpn J Infect Dis. 2022 Jan 24;75(1):31-35. doi: 10.7883/yoken.JJID.2020.1096. Epub 2021 May 31.
8
Clinical characteristics, susceptibility profiles, and treatment of nocardiosis: a multicenter retrospective study in 2015-2021.2015-2021 年多中心回顾性研究:诺卡菌病的临床特征、药敏谱和治疗。
Int J Infect Dis. 2023 May;130:136-143. doi: 10.1016/j.ijid.2023.02.023. Epub 2023 Mar 4.
9
Routine identification of Nocardia species by MALDI-TOF mass spectrometry.通过基质辅助激光解吸电离飞行时间质谱对诺卡氏菌属菌种进行常规鉴定。
Diagn Microbiol Infect Dis. 2017 Jan;87(1):7-10. doi: 10.1016/j.diagmicrobio.2016.09.024. Epub 2016 Oct 4.
10
Lung Nocardia elegans infection diagnosed on matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).经基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)诊断的肺诺卡菌线虫感染。
Intern Med. 2014;53(18):2111-3. doi: 10.2169/internalmedicine.53.2387. Epub 2014 Sep 15.

引用本文的文献

1
Clinical profile and outcomes of pulmonary nocardiosis in India: a systematic review of individual cases.印度肺部诺卡菌病的临床特征与转归:个体病例的系统评价
Infez Med. 2025 Jun 1;33(2):163-174. doi: 10.53854/liim-3302-2. eCollection 2025.
2
Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study.短疗程与标准疗程抗生素治疗诺卡菌病的疗效比较:一项多中心回顾性队列研究
Infection. 2025 Jun;53(3):1115-1127. doi: 10.1007/s15010-024-02445-0. Epub 2024 Nov 26.
3
Metagenome next-generation sequencing plays a key role in the diagnosis and selection of effective antibiotics on the treatment of pneumonia: a case report.
宏基因组下一代测序在肺炎治疗的诊断及有效抗生素选择中起关键作用:一例病例报告
Front Med (Lausanne). 2024 May 27;11:1373319. doi: 10.3389/fmed.2024.1373319. eCollection 2024.